These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 30614347)

  • 1. Testosterone, testosterone therapy and prostate cancer.
    Yassin A; AlRumaihi K; Alzubaidi R; Alkadhi S; Al Ansari A
    Aging Male; 2019 Dec; 22(4):219-227. PubMed ID: 30614347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shifting the paradigm of testosterone and prostate cancer: the saturation model and the limits of androgen-dependent growth.
    Morgentaler A; Traish AM
    Eur Urol; 2009 Feb; 55(2):310-20. PubMed ID: 18838208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of androgen deficiency and replacement on prostate zonal volumes.
    Jin B; Conway AJ; Handelsman DJ
    Clin Endocrinol (Oxf); 2001 Apr; 54(4):437-45. PubMed ID: 11318778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testosterone Therapy on Active Surveillance and Following Definitive Treatment for Prostate Cancer.
    Golla V; Kaplan AL
    Curr Urol Rep; 2017 Jul; 18(7):49. PubMed ID: 28589395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer risk in testosterone-treated men.
    Raynaud JP
    J Steroid Biochem Mol Biol; 2006 Dec; 102(1-5):261-6. PubMed ID: 17113983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancer.
    Mostaghel EA; Page ST; Lin DW; Fazli L; Coleman IM; True LD; Knudsen B; Hess DL; Nelson CC; Matsumoto AM; Bremner WJ; Gleave ME; Nelson PS
    Cancer Res; 2007 May; 67(10):5033-41. PubMed ID: 17510436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testosterone Therapy in Men With Prostate Cancer.
    Kaplan AL; Hu JC; Morgentaler A; Mulhall JP; Schulman CC; Montorsi F
    Eur Urol; 2016 May; 69(5):894-903. PubMed ID: 26719015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men.
    Traish AM
    Adv Exp Med Biol; 2017; 1043():473-526. PubMed ID: 29224108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new era of testosterone and prostate cancer: from physiology to clinical implications.
    Khera M; Crawford D; Morales A; Salonia A; Morgentaler A
    Eur Urol; 2014 Jan; 65(1):115-23. PubMed ID: 24011426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and Treatment of Testosterone Deficiency: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015).
    Khera M; Adaikan G; Buvat J; Carrier S; El-Meliegy A; Hatzimouratidis K; McCullough A; Morgentaler A; Torres LO; Salonia A
    J Sex Med; 2016 Dec; 13(12):1787-1804. PubMed ID: 27914560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline.
    Bhasin S; Brito JP; Cunningham GR; Hayes FJ; Hodis HN; Matsumoto AM; Snyder PJ; Swerdloff RS; Wu FC; Yialamas MA
    J Clin Endocrinol Metab; 2018 May; 103(5):1715-1744. PubMed ID: 29562364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone deficiency syndrome: treatment and cancer risk.
    Raynaud JP
    J Steroid Biochem Mol Biol; 2009 Mar; 114(1-2):96-105. PubMed ID: 19429438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rational approach to androgen therapy for hypogonadal men with prostate cancer.
    Kaufman J
    Int J Impot Res; 2006; 18(1):26-31. PubMed ID: 16208401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High levels of circulating testosterone are not associated with increased prostate cancer risk: a pooled prospective study.
    Stattin P; Lumme S; Tenkanen L; Alfthan H; Jellum E; Hallmans G; Thoresen S; Hakulinen T; Luostarinen T; Lehtinen M; Dillner J; Stenman UH; Hakama M
    Int J Cancer; 2004 Jan; 108(3):418-24. PubMed ID: 14648709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Testosterone Therapy in the Setting of Prostate Cancer.
    Rodriguez KM; Pastuszak AW; Khera M
    Curr Urol Rep; 2018 Jun; 19(8):67. PubMed ID: 29961247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prostate carcinoma and testosterone: risks and controversies].
    Rhoden EL; Averbeck MA
    Arq Bras Endocrinol Metabol; 2009 Nov; 53(8):956-62. PubMed ID: 20126847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of prostate cancer by androgens: experimental paradox or clinical reality.
    Algarté-Génin M; Cussenot O; Costa P
    Eur Urol; 2004 Sep; 46(3):285-94; discussion 294-5. PubMed ID: 15306098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testosterone Therapy and Prostate Cancer.
    Davidson E; Morgentaler A
    Urol Clin North Am; 2016 May; 43(2):209-16. PubMed ID: 27132578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
    Coward RM; Simhan J; Carson CC
    BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical experiences with testosterone therapy: prostate safety.
    Ebert T
    Aging Male; 2004 Dec; 7(4):304-11. PubMed ID: 15799126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.